Report of a WHO workshop on the standardization and control of antivenoms

Toxicon

Volumn 41, Issue 5, 2003, Pages 541-557

  Theakston, R D G ^a   Warrell, D A ^a,b   Griffiths, E ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antivenom; Caprylic acid; Envenoming; Enzyme refinement; Quality control; Standardization; Testing; WHO

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; OCTANOIC ACID; PAPAIN; PEPSIN A; SPIDER VENOM ANTISERUM; VENOM; VENOM ANTISERUM;

ARTICLE; CONTROLLED STUDY; DRUG MANUFACTURE; DRUG SAFETY; FRACTIONATION; HORSE; HUMAN; INSECT STING; ION EXCHANGE CHROMATOGRAPHY; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; RABBIT; SCORPION; SHEEP; SNAKEBITE; STANDARDIZATION;

ANIMALIA; EQUIDAE; ORYCTOLAGUS CUNICULUS; OVIS ARIES; SCORPIONES; SERPENTES;

EID: 0037401660     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(02)00393-8     Document Type: Article

References (19)

1. Abroug F., El Atrous S., Nouira S., Haguiga H., Touzi N., Bouchoucha S. Serotherapy in scorpion envenomation: a randomised controlled study. Lancet. 354:1999;906-909.
2. Calderon-Aranda E.S., Olamendi-Portugal T., Possani L.D. The use of synthetic peptides can be a misleading approach to generate vaccines against scorpion toxins. Vaccine. 13:1995;1198-1206.
3. Chippaux J.-P. Snake bites: appraisal of the global situation. Bull. WHO. 76:1998;515-524.
4. Chotwiwatthanakun C., Pratanaphon R., Akesowan S., Khow O., Sriprapat S., Ratanabanangkoon K. Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol. Toxicon. 39:2001;1487-1494.
5. Freire-Maia L., Campos J.A., Amaral C.F.S. Treatment of scorpion envenoming in Brazil. Bon C., Goyffon M. Envenomings and their Treatments. 1996;301-310 Edition Fondation Marcel Mérieux, Lyon.
6. Ghalim N., El Hafny B., Sebti F., Heikel J., Lazar N., Moustanir R., Benslimane A. Scorpion envenomation and serotherapy in Morocco. Am. J. Trop. Med. Hyg. 62:2000;277-283.
7. 2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use. Toxicon. 36:1998;1523-1528.
8. 2 and Fab of the antivenin. Toxicon. 36:1998;93-114.
9. Laing, G.D., Renjifo, J.M., Harrison, R.A., Nasidi, A., Gutierrez, J-M., Warrell, D.A., Theakston, R.D.G., 2003. Combatting the antivenom crisis: a new polyspecific antivenom for the treatment of snakebites in Snb-Sahara Africa. Br. Med. J., in press.
10. 2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (Terciopelo) snake venom. Toxicon. 35:1997;1627-1637.
11. 2 fragments. Toxicon. 32:1994;725-734.
12. Pratanaphon R., Akesowan S., Khow O., Sriprapat S., Ratanabanangkoon K. Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia). Vaccine. 15:1997;1523-1528.
13. 2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield. Toxicon. 27:1989;297-303.
14. 50) using fertile hens'eggs. Toxicon. 39:2001;665-668.
15. Swaroop S., Grab B. Snake bite mortality in the world. Bull WHO. 10:1954;35-76.
16. Theakston R.D.G., Reid H.A. Development of simple standard assay procedures for the characterization of snake venom. Bull. WHO. 61:1983;949-956.
17. Warrell D.A. South East Asian J. Trop. Med. Pub. Hlth. South East Asian J. Trop. Med. Pub. Hlth. 30 (Suppl. 1):1999;1-85.
18. Progress in the Characterization of Venoms and Standardization of Antivenoms. vol. 58:1981;WHO Offset Publication, WHO Geneva.
19. WHO, 2003. Guideline on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. WHO Technical Report Series (in press).